Nuvo Research announces 2012 third quarter results
Nuvo Research announces 2012 third quarter results
http://drugtreatmentcenterscoloradosprings.com/?post_type=post&p=3348
Nuvo Research announces 2012 third quarter results Filed under: drug treatment news 2012 MISSISSAUGA, ON, Oct. 31, 2012 -- /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug ... Read more on Sacramento Bee
http://drugtreatmentcenterscoloradosprings.com/?post_type=post&p=3348
Nuvo Research announces 2012 third quarter results Filed under: drug treatment news 2012 MISSISSAUGA, ON, Oct. 31, 2012 -- /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug ... Read more on Sacramento Bee
PropThink: Sizing Up Elagolix - A Blockbuster Drug Filed under: drug treatment news 2012 In June 2012, Abbott Labs (NYSE:ABT) initiated a phase III clinical trial with elagolix to evaluate the safety and efficacy of the drug in female patients with endometriosis. Below we .... Importantly, there were no elagolix treatment-related serious ... Read more on Reuters